Skip to content
10-K

Annual Report

THIRD HARMONIC BIO, INC.

0000950170-25-045736

← back to feed
Filed
Mar 27, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 21, 2025 45.1M sh
Shares Diluted FY 2024 · Dec 31, 2024 41.73M sh
Shares Diluted FY 2024 · Dec 31, 2023 39.65M sh
Capex FY 2024 · Dec 31, 2024 $10K
Capex FY 2024 · Dec 31, 2023 $169K
Operating Cash Flow FY 2024 · Dec 31, 2024 −$34.5M
Operating Cash Flow FY 2024 · Dec 31, 2023 −$20.43M
Cash And Equivalents FY 2024 · Dec 31, 2024 $285.06M
Cash And Equivalents FY 2024 · Dec 31, 2023 $269.07M
Stockholders Equity FY 2024 · Dec 31, 2024 $285.15M
Stockholders Equity FY 2024 · Dec 31, 2023 $269.09M
Stockholders Equity FY 2024 · Dec 31, 2022 $289.07M
Current Liabilities FY 2024 · Dec 31, 2024 $7.11M
Current Liabilities FY 2024 · Dec 31, 2023 $5.42M
Total Liabilities FY 2024 · Dec 31, 2024 $9.46M
Total Liabilities FY 2024 · Dec 31, 2023 $8.63M
Current Assets FY 2024 · Dec 31, 2024 $290.54M
Current Assets FY 2024 · Dec 31, 2023 $272.45M
Total Assets FY 2024 · Dec 31, 2024 $294.61M
Total Assets FY 2024 · Dec 31, 2023 $277.71M
Eps Diluted FY 2024 · Dec 31, 2024 $1.09
Eps Diluted FY 2024 · Dec 31, 2023 $0.78
Eps Basic FY 2024 · Dec 31, 2024 $1.09
Eps Basic FY 2024 · Dec 31, 2023 $0.78
Sga Expense FY 2024 · Dec 31, 2024 $22.37M
Sga Expense FY 2024 · Dec 31, 2023 $19.99M
Rd Expense FY 2024 · Dec 31, 2024 $36.5M
Rd Expense FY 2024 · Dec 31, 2023 $23.96M
Net Income FY 2024 · Dec 31, 2024 −$45.47M
Net Income FY 2024 · Dec 31, 2023 −$30.82M
Operating Income FY 2024 · Dec 31, 2024 −$58.87M
Operating Income FY 2024 · Dec 31, 2023 −$43.95M